Superoxide dismutase-2 expression for glaucoma diagnosis
US7807363B2 · kind B2 · utility
5Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 28, 2007 |
| Grant date | Oct 5, 2010 |
| Priority date | — |
| Expiry date | Feb 28, 2027 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/168
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns a method for diagnosing or monitoring elevated intraocular pressure or glaucoma in a patient comprising providing a biological sample from the patient and measuring the expression level of a superoxide dismutase-2 (SOD-2) gene in the biological sample. The present invention also concerns methods for treating glaucoma or elevated intraocular pressure in a patient comprising administering to a patient an effective amount of an agent that modulates SOD-2 expression or SOD-2 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.